dc.contributor.author |
Gadîrcă, Alina |
|
dc.contributor.author |
Bobrov, Elena |
|
dc.date.accessioned |
2021-12-21T08:25:45Z |
|
dc.date.available |
2021-12-21T08:25:45Z |
|
dc.date.issued |
2014 |
|
dc.identifier.citation |
GADÎRCĂ, Alina, BOBROV, Elena. Sensorineural hearing loss syndrome: incidence and methods of treatement. In: MedEspera: the 5th Internat. Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2014, p. 239. |
en_US |
dc.identifier.uri |
http://repository.usmf.md/handle/20.500.12710/19477 |
|
dc.description.abstract |
Introduction: Currently, over 200 million people across the globe suffer from impaired
hearing, a large part of which is caused by ear damage, located in the auditory nerve or cochlea,
which is defined by sensorineural hearing loss. The difficulty of identifying the mechanism of
occurrence of this disease makes it impossible to establish so far, an effective therapy, that would
ensure certainly a satisfactory auricular recovery after administration. Thus, the therapeutic
management of sensorineural hearing loss syndrome remains a very controversial topic, despite
advances in technology, because of a multifactorial pathogenesis and the low recovery rate of
hearing. In Moldova this problem exists and has difficulties in some aspects of this pathology such
as genetic diagnosis and early correction of genetic forms of deafness.
Purpose and objectives: Statistical evaluation of a group of patients diagnosed with
sensorineural hearing loss, and literature analysis on groups of medications used in the treatment of
sensorineural hearing loss.
Materials and methods: Clinical-statistic study according to different criteria of classification.
Results: Our results show an almost equal distribution of cases of congenital sensorineural
hearing loss between the sexes, with a slight predominance of males to the females (51.56% male to
48.44% female). Study the distribution of cases by area of origin showed a higher proportion of patients
in urban areas (59.36% urban versus 40.63% rural). Studying the age group of the 28 cases we have
found that the dominant age group between 11 and 20 to 34.44%. We found that the highest percentage
of patients is represented by those with profound sensorineural hearing loss-11 patients representing
36.5% of all patients. Hearing loss treatment is a combination of remedies including vasodilators,
nootropic and antioxidants. All these remedies used together contribute to improve hemodynamics in
the region of the inner ear, increase metabolism and stimulate the auditory analyzer.
Conclusion: Congenital sensorineural hearing loss remains a very common disease that
requires specific treatment behavior, especially combined. |
en_US |
dc.language.iso |
en |
en_US |
dc.publisher |
Ministry of Health of the Republic of Moldova, State Medical and Pharmaceutical University Nicolae Testemitanu, Medical Students and Residents Association |
en_US |
dc.relation.ispartof |
MedEspera: The 5th International Medical Congress for Students and Young Doctors, May 14-17, 2014, Chisinau, Republic of Moldova |
en_US |
dc.subject |
sensorineural hearing loss |
en_US |
dc.subject |
treatement |
en_US |
dc.subject |
statistic |
en_US |
dc.title |
Sensorineural hearing loss syndrome: incidence and methods of treatement |
en_US |
dc.type |
Other |
en_US |